Back to Browse Journals » Journal of Pain Research » Volume 6

Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury

Authors Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Desai P, Jalundhwala YJ, Botteman M

Published Date July 2013 Volume 2013:6 Pages 539—547

DOI http://dx.doi.org/10.2147/JPR.S45966

Received 30 March 2013, Accepted 16 May 2013, Published 11 July 2013

Sonya J Snedecor,1 Lavanya Sudharshan,1 Joseph C Cappelleri,2 Alesia Sadosky,3 Pooja Desai,4 Yash J Jalundhwala,5 Marc Botteman1

1Pharmerit International, Bethesda, MD, USA; 2Global Research and Development, Pfizer, Groton, CT, USA; 3Biostatistics, Pfizer, New York, NY, USA; 4College of Pharmacy, University of Texas at Austin, Austin, TX, USA; 5Pharmacy Administration, University of Illinois at Chicago, Chicago, IL, USA

Background: Management of neuropathic pain (NeP) associated with spinal cord injury (SCI) is difficult. This report presents a systematic literature review and comparison of the efficacy and safety of pharmacologic therapies for treating SCI-associated NeP.
Methods: Medline, Embase, Cochrane, and Database of Abstracts of Reviews of Effects were searched through December 2011 for randomized, blinded, and controlled clinical trials of SCI-associated NeP meeting predefined inclusion criteria. Efficacy outcomes of interest were pain reduction on the 11-point numeric rating scale (NRS) or 100 mm visual analog scale and proportion of patients achieving ≥30% or ≥50% pain reduction. Discontinuations and adverse events (AEs) were also assessed, for which Bayesian meta-analytic indirect comparisons were performed.
Results: Of the nine studies included in the analysis, samples were <100 patients, except for one pregabalin study (n = 136). Standard errors for the NRS outcome were often not reported, precluding quantitative comparisons across treatments. Estimated 11-point NRS pain reduction relative to placebo was –1.72 for pregabalin, –1.65 for amitriptyline, –1.0 for duloxetine, –1 (median) for levetiracetam, –0.27 for gabapentin, 1 (median) for lamotrigine, and 2 for dronabinol. Risk ratios relative to placebo for 30% improvement were 0.71 for levetiracetam and 2.56 for pregabalin, and 0.94 and 2.91, respectively, for 50% improvement. Meta-analytic comparisons showed significantly more AEs with pregabalin and tramadol compared with placebo, and no differences between placebo and any treatment for discontinuations.
Conclusions: Studies of SCI-associated NeP were few, small, and reported insufficient data for quantitative comparisons of efficacy. However, available data suggested pregabalin was associated with more favorable efficacy for all outcome measures examined, and that the risks of AEs and discontinuations were found to be similar among the therapies.

Keywords: neuropathic pain, spinal cord injury, systematic review, indirect comparison, pharmacologic management

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Cellular prion protein is required for neuritogenesis: fine-tuning of multiple signaling pathways involved in focal adhesions and actin cytoskeleton dynamics

Alleaume-Butaux A, Dakowski C, Pietri M, Mouillet-Richard S, Launay JM, Kellermann O, Schneider B

Cell Health and Cytoskeleton 2013, 5:1-12

Published Date: 11 July 2013

An autopsy case of pulmonary fissure induced by zygomycosis

Imai Y, Adachi Y, Kimura T, Nakano C, Shimizu T, Shi M, Okigaki M, Shimo T, Kaneko K, Ikehara S

International Journal of General Medicine 2013, 6:575-579

Published Date: 11 July 2013

Association of FTO and PPARG polymorphisms with obesity in Portuguese women

Ferreira Carlos F, Silva-Nunes J, Flores O, Brito M, Doria G, Veiga L, Baptista PV

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:241-245

Published Date: 11 July 2013

Anatomy of the Pain Centre waiting list at the Centre hospitalier de l'Université de Montréal (CHUM)

Vargas-Schaffer G, Rusnov A, Boulanger A

Journal of Pain Research 2013, 6:531-537

Published Date: 8 July 2013

Cooled radiofrequency denervation for treatment of sacroiliac joint pain: two-year results from 20 cases

Ho KY, Hadi MA, Pasutharnchat K, Tan KH

Journal of Pain Research 2013, 6:505-511

Published Date: 4 July 2013

Imaging-guided hyperstimulation analgesia in low back pain

Gorenberg M, Schwartz K

Journal of Pain Research 2013, 6:487-491

Published Date: 25 June 2013